| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/17/2009 | US20090233335 Variant humicola Grisea CBH1.1 |
| 09/17/2009 | US20090233333 Methods for preventing gluconoylation of proteins |
| 09/17/2009 | US20090233309 Biological specimen collection/transport compositions and methods |
| 09/17/2009 | US20090233306 diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome; biomarker consisting of between 3 and 35 different nucleic acid probe sets |
| 09/17/2009 | US20090233305 diagnosing whether a subject is likely to have inflammatory bowel disease (IBD) by detecting formation of hybridization complexes between the 2 or more probe sets and nucleic acid targets in the nucleic acid sample |
| 09/17/2009 | US20090233304 diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome; biomarker consisting of between 3 and 35 different nucleic acid probe sets |
| 09/17/2009 | US20090233296 Thiamin production by fermentation |
| 09/17/2009 | US20090233290 Mutant SepRS, and method for site-specific introduction of phosphoserine into protein using the same |
| 09/17/2009 | US20090233281 Diagnostic marker for allergy |
| 09/17/2009 | US20090233278 Branched-chain amino acid aminotransferase gene and use thereof |
| 09/17/2009 | US20090233277 Primer generation rolling circle amplification |
| 09/17/2009 | US20090233274 Drug development target protein and target gene, and method of screening |
| 09/17/2009 | US20090233272 Multiplexed Nucleic Acid Analysis with High Specificity |
| 09/17/2009 | US20090232843 Identifying and predicting influenza variants and uses thereof |
| 09/17/2009 | US20090232842 HPV Vaccine Comprising Peptides From Host Cell Proteins |
| 09/17/2009 | US20090232841 Optimzed vaccines to provide protection against ebola and other viruses |
| 09/17/2009 | US20090232837 Anti tumoral immunogenic peptides and vaccine thereof |
| 09/17/2009 | US20090232833 Polyalkylene oxides having hindered ester-based biodegradable linkers |
| 09/17/2009 | US20090232830 Modified HIV-1 Envelope Proteins |
| 09/17/2009 | US20090232826 Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2 |
| 09/17/2009 | US20090232822 Lung disease targets and uses thereof |
| 09/17/2009 | US20090232820 Neisseria meningitidis antigens and compositions |
| 09/17/2009 | US20090232803 Antibodies to human il-1beta |
| 09/17/2009 | US20090232801 Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof |
| 09/17/2009 | US20090232800 E1-minus adenoviruses and use thereof |
| 09/17/2009 | US20090232797 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/17/2009 | US20090232795 1b20 pcsk9 antagonists |
| 09/17/2009 | US20090232794 Modulators of neuronal regeneration |
| 09/17/2009 | US20090232788 Enzyme With Microbial Lysis Activity From Trichoderma Reesei |
| 09/17/2009 | US20090232773 Method for Distinguishing Mesenchymal Stem Cell Using Molecular Marker and Use Thereof |
| 09/17/2009 | US20090232771 Method of controlling cell functions |
| 09/17/2009 | US20090232736 Dual specificity antibodies and methods of making and using |
| 09/17/2009 | CA2722479A1 Rna-selective hybridization reagent and use of the same |
| 09/17/2009 | CA2717994A1 Target amplification and sequencing with primers comprising triplex forming monomer units |
| 09/17/2009 | CA2717637A1 Use of sirna to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a desired polynucleotide |
| 09/17/2009 | CA2717320A1 Nucleic acid-based tests for prenatal gender determination |
| 09/16/2009 | EP2100971A2 Real-time sequence determination |
| 09/16/2009 | EP2100620A1 Nucleic acids encoding polyepitope polypeptides |
| 09/16/2009 | EP2099935A2 Array for detecting microbes |
| 09/16/2009 | EP2099931A2 Use of lecithin:retinol acyl transferase gene promoter methylation in evaluating the cancer state of a subject |
| 09/16/2009 | EP2099928A2 Two-stage nucleic acid amplification using an amplification oligomer |
| 09/16/2009 | EP2099825A2 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same |
| 09/16/2009 | EP2099438A2 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 09/16/2009 | EP1699931B1 Maize metallothionein 2 promoter and methods of use |
| 09/16/2009 | EP1478656B1 Oligonucleotide compositions with enhanced efficiency |
| 09/16/2009 | EP1463836B1 Vector mediated organelle transfection |
| 09/16/2009 | EP1414948B1 Inhibition of apoptosis process and improvement of cell performance |
| 09/16/2009 | EP1149109B1 Method for deprotecting oligonucleotides |
| 09/16/2009 | EP1100815B1 Protease susceptibility ii |
| 09/16/2009 | CN101535332A Methods for improving antibody production |
| 09/16/2009 | CN101535331A Human micrornas and methods for inhibiting same |
| 09/16/2009 | CN101532046A Site-specific incorporation of redox active amino acids into proteins |
| 09/15/2009 | US7589264 Maize variety 36V52 |
| 09/15/2009 | US7589258 Expression vector comprising farnesyltransferase polypeptide for use in propagation and generation of plants with improved water stress tolerance |
| 09/15/2009 | US7589257 Recombinant expression cassettes, host cells, and transgenic plants; ferredoxin NADP+ reductase |
| 09/15/2009 | US7589192 pH dependent ion exchange material capable of selectively binding to nucleic acids in comparison with proteins, solid substrate having the material immobilized on its surface, and method of isolating a nucleic acid using the material or the solid substrate |
| 09/15/2009 | US7589191 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response |
| 09/15/2009 | US7589190 Potent LNA oligonucleotides for the inhibition of HIF-1A expression |
| 09/15/2009 | US7589189 By using a double-stranded RNA (dsRNA); neurodegenerative disorder |
| 09/15/2009 | US7589187 Identify and/or desensitize an animal susceptible to an allergic response to a mite; high molecular weight |
| 09/15/2009 | US7589186 Isolated hOAT polynucleotide |
| 09/15/2009 | US7589185 Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis |
| 09/15/2009 | US7589181 Humanized anti-TAG-72 CC49 monoclonal antibodies; retain binding affinity for TAG-72 and have reduced immunogenicity, as compared to a parental HuCC49V10 antibody; carcinoma; antitumor agent |
| 09/15/2009 | US7589178 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2009 | US7589177 Nucleic acid molecules encoding cyclotide polypeptides and methods of use |
| 09/15/2009 | US7589174 GRP94-based compositions and methods of use thereof |
| 09/15/2009 | US7589074 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function; chronic synovitis, autoimmune diseases, rheumatoid arthritis |
| 09/15/2009 | US7589073 Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
| 09/15/2009 | US7588941 Using electrophoresis to separate DNA conjugated nanostructures; semiconductors; biosensors |
| 09/15/2009 | US7588933 Nucleotide sequences for detecting enterohaemorrhagic Escherichia coli (EHEC) |
| 09/15/2009 | US7588931 Oleaginous yeast Yarrowia lipolytica capable of producing greater than 10% arachidonic acid (ARA, an omega -6 polyunsaturated fatty acid) in the total oil fraction; desaturase |
| 09/15/2009 | US7588930 Fusing to the antigen a Listerial truncated ActA protein; listeria vaccine strain |
| 09/15/2009 | US7588928 Enzymatic polypeptide comprising halogenase activity for use in production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters; bioremediation; pollution control |
| 09/15/2009 | US7588925 Isolated from Aspergillus niger; used in industrial processes and methods of diagnosing fungal infections; reducing phospholipid content of an edible oil; baked goods |
| 09/15/2009 | US7588922 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use |
| 09/15/2009 | US7588921 Facile identification of the tissue components present in a body fluid stain; assay format that -provides greater specificity in the identification of body fluids with improved timeliness; decrease sample consumption during analysis |
| 09/15/2009 | US7588920 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 09/15/2009 | US7588915 Isolated genomic polynucleotide fragments from chromosome 7 |
| 09/15/2009 | US7588914 Bacterial Bcl-2 domain-containing polypeptides, encoding nucleic acid molecules, and related methods |
| 09/15/2009 | US7588897 Detection probes for detection of indicator enterococci 23S rRNA sequences using methods of specific nucleic acid amplification and detection |
| 09/15/2009 | US7588896 Detecting a target polynucleotide sequences; ligation and amplification reactions that generate self-complementary polynucleotide products |
| 09/15/2009 | US7588894 Use of ID4 for diagnosis and treatment of cancer |
| 09/15/2009 | US7588889 Chemical arrays and methods of using the same |
| 09/15/2009 | US7588888 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 09/15/2009 | US7588886 Process for the enumeration and identification of microorganisms |
| 09/15/2009 | US7588773 vaccines; use for detecting a group B streptococcus serotype III, RDP III-3 strain; drug screen an agent for inhibiting adhesion of a group B streptococcal cell to a host cell |
| 09/15/2009 | US7588758 A genetic vector comprising a promoter linked to an expression cassette able to express a cyclooxygenase protein; treating bone disorder osteoporosis, heterotopic ossification |
| 09/15/2009 | US7588755 Immunomodulation by administration of a recombinant polypeptide produced by a non-human host transformed by a recombinant DNA molecule ; antiviral and antitumor or anticancer agents |
| 09/15/2009 | CA2396058C Methods for isolating and characterizing endogenous mrna-protein (mrnp) complexes |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/15/2009 | CA2136859C Use of genetic markers to diagnose familial dysautonomia |
| 09/11/2009 | WO2009111599A2 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/11/2009 | WO2009111493A1 Viral microrna |
| 09/11/2009 | WO2009091847A3 Compositions, methods and systems for single molecule sequencing |
| 09/11/2009 | WO2009088255A3 Method for preparing antigen effective for preventing anthrax infection |
| 09/11/2009 | WO2009086132A3 Design of spacers to increase the expression of recombinant fusion proteins |
| 09/11/2009 | WO2008067427A3 Insulin-like growth factor-1 receptor antagonists for modulation of weight and liposity |
| 09/11/2009 | WO2007106603A3 Specific labeling of proteins with zinc finger tags and use of zinc-finger-tagged proteins for analysis |
| 09/11/2009 | CA2717070A1 Gel microdrop composition and method of using the same |
| 09/11/2009 | CA2716793A1 Compositions and methods for inhibiting expression of eg5 and vegf genes |